Of reported sightings between 2020 and 2025 in Acadia, about 60% occurred just in 2025. “I believe this is because there were some bear conflicts early in the year,” said a lead researcher.
Recent advances in medicines can be tailored to the specific mutation that causes a given rare disease, paving the way toward a new model for treating rare disease.
The funding will allow the Biddeford-based university to invest in specialized equipment for use by researchers, companies and institutions across the region.
Co-hosted by Bigelow Laboratory for Ocean Sciences and Hatch Blue, with support from the Maine Technology Institute, the event is designed to accelerate the translation of ocean research into commercial opportunities.
The collaboration integrates JAX’s expertise in genetics, disease biology and stem cell research with GSK’s in neurodegeneration and drug discovery. The goal is to help close a gap between scientific discovery and the development of new medicines.
The use and development of tech and wood-based products — like LiDAR and cross-laminated timber — could be advanced if the $15 million, two-year grant is awarded.